The advent of miniaturized assay formats has made possible the screening of large numbers of compounds against a single target, known as high-throughput screening. Despite this clear advantage, assay miniaturization also increases the risk of ligand depletion, where the actual concentration of free ligand is significantly lower than that added. This, in turn, complicates the interpretation of data from such assays, potentially introducing significant error if not recognized. In this study, the effects of reducing assay volume on radioligand Kd and competitor Ki values have been investigated, using the muscarinic M 3 receptor as a model system. It was found that assay miniaturization caused dramatic effects, with up to a 30-fold underestimation of ligand affinity. A theoretical model was developed and shown to accurately predict both the degree of ligand depletion in any given assay volume and the effect of this depletion on affinity estimates for competing ligands. Importantly, it was found that in most cases, errors introduced by ligand depletion could be largely corrected for by the use of appropriate analysis methods. In addition to those previously described by others, the authors propose a simple method capable of correcting errors in competition binding experiments performed in conditions of ligand depletion. (Journal of Biomolecular Screening 2007:255-266) 
INTRODUCTION
I N RECENT TIMES, there has been a gradual trend toward assay miniaturization in the drug discovery environment, allowing increased compound throughput, reduced cost, and conservation of compound. Radioligand binding assays are often run in a 50-to 100-µL assay volume and fluorescence assays in even smaller volumes, in 384-or 1536-well plates. The concentration of receptor is usually increased in these low-volume assays to maintain adequate signal sizes. Conversely, the concentration of radioligand may be kept to a minimum to reduce costs and increase assay sensitivity.
When using high-affinity ligands in such assay systems, there is a risk that the results will be affected by ligand depletion, where binding of ligand to the receptor will result in a reduction in the free ligand concentration. In these situations, it can no longer be assumed that the free ligand concentration is equal to the concentration added. Instead, the free ligand concentration should be measured directly and used in the analysis, controlling for the effects of ligand depletion. 1 This is, however, seldom done. Indeed, it can be very difficult to measure the free ligand concentration in some homogeneous assay formats, where sampling the free fraction may require separation using high-speed centrifugation steps. Although some newer fluorescence-based detection systems (e.g., fluorescence correlation spectroscopy) are able to measure free ligand concentration, it is certainly not possible under most high-throughput conditions. Many theoretical analyses of ligand depletion in radioligand binding assays have been carried out [1] [2] [3] [4] [5] [6] and reviewed, 7, 8 although few experimental investigations have been published. Recommendations have been made for ensuring that assay conditions are optimized to avoid ligand depletion (e.g., the concentration of receptors should be less than 10% of the ligand's Kd, such that less than 10% of the ligand will be bound to receptor). 2 However, these assay conditions are often not compatible with miniaturized assay formats, resulting in a conflict between practicality and correct practice. An alternative approach is to use analysis techniques that take radioligand depletion into account, 6, 7, 9 although it is suggested that such analyses should only be used with levels of depletion less than 50%. 7 In this report, we present data obtained in a radioligand binding assay for the human muscarinic M 3 receptor, exploring the effect of radioligand depletion on affinity determinations for both radioligand and competing compounds. We compare these experimental data with those obtained from computer simulations, using a theoretical model of receptor ligand binding. We also compare standard data analysis with analysis techniques that take ligand depletion into account.
Finally, we offer a simple, novel solution for obtaining accurate affinity constants for competing ligands in situations where significant ligand depletion cannot be avoided.
MATERIALS AND METHODS

Preparation of CHO-M 3 membranes
Chinese hamster ovary (CHO-K1) cells transfected with the human muscarinic M 3 receptor (CHO-M 3 ) were a generous gift from Prof. S. R. Nahorski and Prof. R. A. J. Challiss, Department of Cell Physiology and Pharmacology, Leicester University.
CHO-M 3 cells were cultured in MEM alpha without ribonucleosides and deoxyribonucleosides, supplemented with 10% (v/v) newborn calf serum. All cell culture reagents were purchased from Invitrogen (Carlsbad, CA). The media were removed and ice-cold cell dissociation buffer (10 mM HEPES, 0.9% NaCl, 0.2% EDTA [pH 7.4]) added. The cells were incubated for 10 min and then scraped from the flask. The cells were pelleted and resuspended in homogenization buffer (10 mM HEPES, 10 mM EDTA [pH 7.4]). The cells were homogenized using a Polytron homogenizer and centrifuged (40,000 g, 25 min, 4 o C). The pellet was resuspended in storage buffer (10 mM HEPES, 0.1 mM EDTA [pH 7.4]), snap frozen, and stored at -80 o C. Protein concentration was determined using a Bradford assay. 10
M 3 receptor radioligand binding assay
CHO-M 3 membranes, expressing 4.97 ± 0.14 pmol receptor per mg protein (n = 3 separate experiments), were incubated with the required concentration of 1-[N-methyl-3 H] scopolamine methyl chloride ([ 3 H]NMS; Amersham, Buckinghamshire, UK), with or without test ligand, or a saturating concentration of atropine (10 µM) for the determination of nonspecific binding. The assay was carried out in 96-well polypropylene plates, in the stated assay volume. The assay buffer used was 20 mM HEPES, 1 mM MgCl 2 (pH 7.4). The final assay concentration of DMSO was 1% (v/v). The plates were sealed and incubated for 1.5 h at room temperature, on an orbital shaker (slow speed).
Membranes were harvested onto Unifilter GF/B plates (PerkinElmer, Boston, MA) pretreated with 0.05% (v/v) polyethyleneimine, using a Brandel filtration harvester (9600, Semat International, St. Albans, UK), washing 3 times with 1 mL assay buffer (4 o C).
The plates were dried (2 h, 35 o C) before addition of 50 µL Microscint-0 (PerkinElmer). The plates were sealed and read on TopCount (PerkinElmer).
Theoretical computer simulations
Using the following equations, the fraction of receptor bound to radioligand, A (fAR), and the percent depletion were determined under various conditions:
The derivation of these equations is given in the appendix.
Data analysis
All data were analyzed in Excel (MicroSoft) and curves fitted to the data in GraphPad Prism (GraphPad Software, Inc., San Diego, CA). The F-test was used to determine the statistically bestfitting curve to any data set.
RESULTS
Kd determinations at the M 3 receptor
To test the impact of ligand depletion on apparent radioligand affinity (Kd) in miniaturized assays, a range of assay conditions was chosen that mirror those employed in many in vitro assays. A range of assay volumes (50 µL, 100 µL, 250 µL, or 1750 µL) was tested to simulate miniaturized assays through to deep-well 96-well microplates. In addition, at each of these volumes, a range of CHO-M 3 membrane concentrations was chosen (5 µg, 15 µg, 25 µg, or 50 µg membrane per well). [ 3 H]NMS saturation binding curves at the human M 3 receptor were then constructed under each of these assay conditions (Fig. 1) .
The time required to achieve equilibrium is also affected by the concentration of radioligand and receptor and may increase under conditions of ligand depletion. 7 In this study, however, we found that the results of the saturation binding studies for the M 3 receptor were not affected when the assay was terminated at 1.5 h compared with 6 or 24 h (data not shown).
The [ 3 H]NMS saturation binding curves shifted to the right as the volume was decreased and as the amount of membrane was increased. A 1-site hyperbola did not accurately describe the data with high membrane concentrations. When the data were replotted on a logarithmic scale, a sigmoidal curve with variable slope was found to better fit the data (F-test; Fig. 2 ). When analyzed in this way, the Kd shifted to the right with increasing receptor concentration, by up to 30-fold ( Table 1 ). In addition, the slope of the curve became steeper with increased receptor concentration.
.
Scaramellini Carter et al. In situations with significant ligand depletion, specific binding should be plotted against free radioligand concentration, rather than total added to the well. The free [ 3 H]NMS concentration was estimated from total [ 3 H]NMS added minus total bound (including any nonspecific binding), and this was plotted versus specific [ 3 H]NMS bound. The resulting Kd values were lower than those obtained by plotting against total added but were still dependent on receptor concentration ( Table 1) .
Ligand Depletion in Miniaturized Binding Assays
The data were also analyzed in Prism using a model 9 based on the method proposed by Swillens, 6 which fits a curve to total binding, accounting for nonspecific binding and ligand depletion (Kd values calculated using this method are detailed in Table 1 ). Analysis of total binding resulted in much more consistent Kd values, even under very depleted conditions. In some cases, however, where the experimental window was small due to low amounts of membrane present, this analysis was unable to fit the data and so could not derive a Kd value. In other cases, Kd values were predicted, but these had considerable interexperimental variability (see Table 1 and Fig. 3) .
A plot of experimental Kd versus log receptor concentration has been predicted to plateau at the "true" Kd. 2 Figure 3 shows receptor concentration plotted against the experimental Kd values obtained using both total and free radioligand concentration. Kd values from both analysis methods reached a similar predicted plateau at infinitely low receptor concentration (33.9 pM from total and 32.3 pM from free). For comparison, Figure  3 also shows each replicate of the Kd values derived from the total binding model (Swillens 6 ). As can be seen, the Kd values derived from this method were at times highly variable, although the mean Kd of 41.0 ± 2.8 pM was similar to that derived from the plateau of the specific binding data.
Computer simulation of the effects of ligand depletion on apparent Kd
A model was developed to predict the level of ligand depletion in different assay conditions and its subsequent impact on apparent radioligand Kd (see the appendix for detail). To test this model, saturation binding curves were simulated for a ligand with affinity 34 pM and a receptor expression level of 4.97 pmol/mg protein, using the same receptor concentrations as used experimentally. Data generated under these conditions were plotted as previously ( Fig. 4) and, like the experimental data, were better fit by sigmoidal curves (variable slope) on a logarithmic scale. A comparison of the affinities derived experimentally with those predicted from the simulations is detailed in Table 1 and shown graphically in Figure 5 . The correlation between the data sets was good (r 2 = 0.86), although the model consistently overestimated the radioligand affinity in each condition by approximately 2-fold. This error is most likely due to additional ligand depletion resulting from nonspecific interactions that were not considered in the model. Despite this, these data show that in this system, it is feasible to use a theoretical model to estimate the effect of ligand depletion on the experimental Kd determined from a radioligand binding assay.
Although the effects of ligand depletion can be largely overcome by using an appropriate analysis method (as described above), the optimal approach is to determine the Kd of a radioligand in conditions where ligand depletion is minimal. This can be achieved either by using a low amount of membrane (which may result in a small signal size) or by using a large assay volume (which may mean running the assay in a different format). The model can be used to assist in the optimal choice of assay conditions, by predicting the level of ligand depletion at different receptor concentrations. The percentage depletion of radioligand is defined by equation (2).
At low concentrations of radioligand, as the free concentration of receptor, [R], tends to [Rtot], the % depletion therefore tends to equation (3).
Using equation (3), it was possible to calculate that to reduce ligand depletion to less than 10% across the whole concentration range of [ 3 H]NMS used to construct a saturation binding curve, it would be necessary to use a receptor concentration of ≤ 3.7 pM. This could be achieved by using 5 µg membrane per well in an assay volume of ≥ 6.7 mL. This was in accordance with the experimental data, where it was observed that even at the conditions with lowest levels of ligand depletion (5 µg membrane in 1.75 mL; receptor concentration of 14.1 pM), depletion at 34 pM [ 3 H]NMS was 18.7%, resulting in an almost 3-fold underestimation of the Kd.
At the apparent Kd, as the free concentration of receptor, [R], is equal to 0.5 [Rtot], we can define the % depletion at a concentration of radioligand equal to the apparent Kd according to equation (4).
The % depletion of radioligand at the Kd concentration (34 pM) is shown in Table 1 for each of the conditions tested. There was a large degree of depletion in many of the conditions, reaching 99.3% at the highest receptor concentration.
The effects of ligand depletion on competition binding experiments
In competition binding assays, the concentration of radioligand chosen is often close to its Kd. Using equation (4), it is possible to predict the assay conditions required to minimize ligand depletion (to less than 10% bound) at a radioligand concentration suitable for competition experiments. This was applied to the M 3 receptor binding assay with a Kd concentration of
. Figure 2 were analyzed in 3 different ways: ( ) the Kd was determined by plotting specific bound versus the negative logarithm of total radioligand added and then fitting to a sigmoidal curve with variable slope. ( ) The Kd was determined by plotting specific bound versus the free concentration of radioligand (total bound) and then fitting to a sigmoidal curve. These Kd values were plotted against receptor concentration and fitted with exponential decay curves, with the plateaus denoting the "true" Kd (i.e., the Kd that would be obtained in the absence of ligand depletion). Data are mean ± SEM of the 3 separate experiments. ( ) The Kd was determined by fitting the total binding data using a model based on that described by Swillens. 6 The broken line represents the mean value from this data set, which are shown as the individual replicates from the 3 separate experiments to demonstrate the variability of Ki values predicted.
Ligand Depletion in
(34 pM), and it was found that the receptor concentration should be less than 8 pM. This could be achieved using 5 µg membrane per well in a 3.1-mL assay volume, which would give a reasonable signal size (~1000 cpm), but would not be suitable for testing large numbers of compounds. Alternatively, a 96-well compatible assay volume of 200 µL could be used, but the membrane amount would have to be reduced to 0.3 µg per well, which would not give sufficient counts. An alternative way to reduce ligand depletion is to use a higher concentration of radioligand. For example, with 5-µg membrane in a 200-µL assay volume, a radioligand concentration of 1.2 nM would be less than 10% depleted. This would, however, result in a less sensitive assay (radioligand concentration 35-fold over its Kd), meaning that compounds may not be detected as hits in high-throughput screening (discussed in more detail later) or that full competition binding curves may not be obtained for lower affinity compounds.
As it is apparent that the conditions required to minimize ligand depletion are often not compatible with compound screening, we investigated the degree of influence ligand depletion can have on affinity measurements for test compounds using competition Under each condition, competition binding curves were constructed using a concentration of [ 3 H]NMS equal to its apparent Kd for that assay condition, rather than the "true" Kd of 34 pM. This mimics a situation where ligand depletion is present but is overlooked.
As shown in Figure 6 and Table 2 , the IC 50 values obtained under the different conditions were found to vary by up to 30-fold, with compounds appearing to have lower affinity in conditions of higher ligand depletion. The main factor in this variation is likely to be the large difference in concentration of radioligand added in each condition. Using the apparent Kd for each assay condition to derive the Ki from the IC 50 (using the Cheng-Prusoff equation 11 ) resulted in Ki values that also varied by up to 30-fold depending on the assay conditions (see pKi(i) in Table 2 and Fig. 7) .
These data were also fitted to an equation that accounts for depletion of the radioligand in heterologous competition assays, as described by Motulsky and Christopoulos. 9 This equation corrected well for the effects of ligand depletion, shown in Table 2 and was found that by using the "true" Kd of 34 pM, it was possible to largely correct for the effects of ligand depletion on the Ki for each compound tested. We have termed these values as "corrected" Ki. In each case, the "corrected" Ki determined under conditions with a large amount of ligand depletion was not statistically different to that obtained under conditions with little ligand depletion (p > 0.05, Student t-test). Figure 8 shows simulated data for a competing ligand with 10 nM affinity, at different levels of depletion. When the apparent radioligand Kd was used in the Cheng-Prusoff equation, the calculated affinity of the competitor was considerably underestimated under conditions with radioligand depletion. In contrast, when the "true" radioligand Kd was used to calculate the Ki, values within 2-fold of the correct competitor Ki were obtained, even with levels of depletion approaching 90%. The best estimate of the Ki was obtained when the radioligand concentration was equal to the apparent Kd. Under these conditions, at radioligand depletion levels as high as 99.3%, a Ki value of 16 nM was observed (1.6-fold underestimation of compound affinity). Under these same conditions, if the apparent Kd were used in the Cheng-Prusoff equation, the calculated Ki would be 1189 nM, underestimating the compound affinity by more than 100-fold. Similar data were simulated using a wide variety of parameter values, and in each case, the same observations were made (data not shown). Thus, the recommendation for achieving valid estimates of compound affinity even under conditions of high ligand depletion is to use a radioligand concentration close to the apparent Kd but to calculate the compound Ki using the true Kd in either the Cheng-Prusoff equation or with an analysis method that accounts for radioligand depletion.
Ligand depletion in single-point inhibition assays
The approach detailed above provides a solution for correcting for the effects of ligand depletion in competition binding curve studies. Such an approach cannot, however, be used when testing compounds at a single concentration-for instance, when testing large compound libraries or during a highthroughput screening campaign. To examine the influence of ligand depletion in single-point competition assays, the computer model was used to simulate the percentage inhibition by a compound with Ki of 1 µM at a screening concentration of 10 µM in the 3 different assay conditions described in the previous section (i.e., receptor concentration of 14, 298, and 2485 pM). As discussed earlier, ligand depletion can also be overcome in competition assays by increasing the radioligand. We therefore also examined the percentage inhibition at 3 different radioligand concentrations (0.3, 1, and 3 times the apparent Kd). The expected percentage inhibition at these radioligand concentrations in the absence of depletion (according to the Gaddum equation 12 ) is 97.3%, 91.7%, and 78.6%, respectively. Under each condition, the percentage depletion of radioligand in the absence of competitor was also calculated. Figure 9 shows that the percentage inhibition observed was dependent on the assay conditions used. As the receptor concentration was increased, the degree of inhibition elicited by 10 µM of the compound (Ki = 1 µM) decreased. Indeed, if a 50% inhibition of binding was taken as a cutoff point to select actives, then the compound would be missed where [receptor] = 2485 pM and borderline where [receptor] = 298 pM. Only at the [receptor] of 14 pM would the compound be unambiguously selected.
As would be expected, increasing the concentration of radioligand significantly reduced the level of depletion in each assay condition. This did not, however, improve the sensitivity of the assay, due to the greater degree of competition (as expected according to the Cheng-Prusoff equation). For example, the lowest level of depletion observed was 8% at a [receptor] of 14 pM and 3-fold Kd concentration of radioligand. Under these conditions, the percentage inhibition was 71.3%, compared to the 78.6% expected with no depletion. Despite this low level of depletion, however, this assay setup was less sensitive than with 0.3-fold Kd concentration of radioligand, where the depletion was 25%, but percentage inhibition was 85.6%.
It is apparent from this simulation that although ligand depletion can be reduced by increasing the concentration of radioligand in the assay, this results in a less sensitive assay that may still miss active compounds in a single-point screen.
DISCUSSION
This study has illustrated the degree of distortion in apparent ligand affinities that can be observed if binding assays are performed under conditions of radioligand depletion. A theoretical model of 2 competing ligands binding to a receptor was found to accurately predict the effect of ligand depletion on the apparent Kd and IC 50 determinations. If the radioligand affinity and the receptor expression level are known, then this model may be used to design assay conditions where ligand depletion is minimized. It is recognized, however, that in a screening environment where assay cost, robustness, and throughput are important considerations, the optimum assay conditions for minimizing ligand depletion may not be realistic for routine use. To obtain a reasonable signal size, in an assay volume suitable for use in 96-or 384-well assay plates, the optimal conditions for screening may often result in a high degree of radioligand depletion. We have therefore assessed the utility of several different methods for correcting for error introduced by ligand depletion.
Kd values derived from radioligand saturation experiments were significantly underestimated under conditions with high levels of ligand depletion. To account for this depletion, we estimated the free concentration of [ 3 H]NMS by subtracting total bound (including any nonspecific binding) from total added and plotted this against specific bound radioligand. Surprisingly, despite partially correcting the data, the Kd values obtained using this method were still highly dependent on receptor concentration, suggesting there was considerably more depletion of radioligand than assumed. This could be explained if a large component of bound radioligand dissociated from the receptor during the filtration step, leading to an underestimation of receptor concentration and therefore degree of depletion in the well. Although this may occur with low-affinity radioligands, it is unlikely that a significant portion of bound [ 3 H]NMS dissociated within the timeframe of filtration, as [ 3 H]NMS has relatively slow dissociation kinetics (k off = 0.017 min -1 ). 13 Alternatively, the filtration process may not have trapped all the membranes, again underestimating receptor concentration and degree of ligand depletion. To test this, we performed experiments using high-speed centrifugation instead of filtration and found that the same amount of bound [ 3 H]NMS was recovered (data not shown).
This implies that the nonspecific binding data obtained with 10 µM atropine significantly underestimated the total level of nonspecific binding. Nonspecific binding can be difficult to determine in situations with high levels of ligand depletion. In the presence of a saturating concentration of cold competitor, nonspecific binding may be greater than in its absence. This is because when binding of the radioligand to receptor is prevented, ligand depletion is reduced, and free radioligand concentration approaches total added. This higher concentration of radioligand will bind to more nonspecific sites (in a linear fashion). For this reason, it can be more accurate to plot total binding against free [radioligand] and nonspecific binding to total [radioligand]. This does not, however, account for the error observed in this study where nonspecific binding was underestimated in the presence of cold competitor. It is possible that atropine, which is structurally related to NMS, displaced the radioligand from nonspecific sites in addition to receptor sites. Another source of nonspecific binding could be low-affinity interactions that are subsequently washed off during the filtration step. This would reduce the free [radioligand] in the well during the incubation step but would be undetectable after filtration.
To avoid complications associated with underestimation of nonspecific binding, we used an analysis method that does not rely on an experimentally determined nonspecific binding value: that of Swillens. 6 In this method, total radioligand bound is analyzed assuming 2 components: saturable binding to a specific receptor site according to the Hill-Langmuir binding isotherm 14, 15 and linear binding to nonspecific sites. When total binding data were analyzed in this manner, errors introduced by ligand depletion were largely corrected for, yielding a mean Kd value that was in good agreement with those obtained from extrapolation of Kds at different receptor concentrations. An important consideration when applying this analysis method is that it requires knowledge of the counting efficiency to generate a specific activity of the radioligand in cpm/fmol, which may not be straightforward in some assay formats (e.g., scintillation proximity assays [SPAs]). In addition, we found that accurate fits and good Kd estimates were heavily dependent on high-quality experimental data. Despite these issues, the method of Swillens 6 appears to be the most appropriate method for estimating radioligand affinity in situations of ligand depletion.
We compared 2 methods for determining the correct Ki under conditions of ligand depletion. First, Ki values were determined using a method that accounts for ligand depletion in the analysis of competition binding curves 9 (method ii), and second, the correct Kd was simply used with the Cheng-Prusoff equation (method iii). Both methods generated very similar results, largely correcting for the effects of ligand depletion. Because both methods require knowledge of the true radioligand Kd, there appears to be no advantage of accounting for ligand depletion in the curve fitting over simply using the correct Kd in the Cheng-Prusoff equation. In addition, the first analysis requires knowledge of counting efficiency to determine the specific activity of the radioligand in cpm/fmol, which, as discussed above, can be difficult to determine in some assay formats (e.g., SPA). The accuracy of the Ki values generated in the competition experiments can be tested by comparing the Ki for unlabeled N-methyl scopolamine with the Kd for [ 3 H]N-methyl scopolamine. It was found that the average Ki from method ii or iii (77 and 60 pM, respectively) was only 2-fold greater than the Kd derived from the saturation plots (34 pM). This small difference was probably due to depletion of the unlabeled compound in the competition experiments, as the methods described above account for depletion of the radioligand but not that of unlabeled competitor. Depletion of competitor compound is an important consideration, particularly when testing compounds with similar or higher affinity to the radioligand. To obtain accurate affinity determinations for these ligands, it would be necessary to reformat the assay to reduce the levels of ligand depletion.
In conclusion, we have demonstrated both experimentally and theoretically that in a modern compound screening environment, ligand depletion can, at times, be difficult to avoid. It is possible, however, to still obtain accurate compound affinity values from assays with ligand depletion if the experimental and analytical approaches are appropriate. Where ligand depletion cannot be avoided in competition binding assays, we recommend selecting a radioligand concentration close to the apparent Kd for use experimentally but then calculating the compound Ki using the true Kd in either the Cheng-Prusoff equation directly or with a curve-fitting method that accounts for radioligand depletion.
APPENDIX Theoretical Computer Simulations
For 2 ligands A and B, binding to receptor, R, with affinities K A and K B , respectively to give AR and BR, the total receptor concentration [Rtot] is given by The roots are then given by Root 1 is found to be the physiologically relevant root. The fraction of receptors bound to the radioligand A in the absence of B, fAR, is given by 
